On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayFeb 20, 2024 4:20 pm

420 with CNW — Navy Expands Cannabis Waiver as Recruitment Nosedives

The Navy is changing its policy for recruits who test positive for cannabis upon arriving at boot camp, choosing to grant waivers rather than dismiss them outright in light of the continuous difficulties the United States military faces in recruiting. Head of the Navy’s personnel policy and plans unit, Rear Admiral James Waters, explained that if a recruit tests positive for cannabis and admits to using it, an assessment is done to make sure there are no underlying problems. The adaptation aims to align with social laws and provide an opportunity for young people to acclimate to the Navy’s culture…

Continue Reading

TuesdayFeb 20, 2024 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Doubles Down on GLP-1 Clinical Studies for 2024; Terms 2023 as its Most Successful and Active Year of R&D

Lexaria, a global innovator in drug delivery platforms to enhance bioavailability, announced recently that it will focus on GLP-1 applications for diabetes and weight loss for the 2024 calendar year Chris Bunka, Lexaria’s CEO, has expressed his confidence in the company’s direction, reiterating the intention to demonstrate the superior performance of GLP-1 drugs processed with its patented DehydraTECH(TM) technology The company looks to build on the success of the early-stage results achieved in 2023, and looks to embark on two human pilot studies, a multi-arm 12-week animal chronic study, a human chronic weight-loss and diabetes study, as well as a…

Continue Reading

FridayFeb 16, 2024 4:20 pm

420 with CNW — Operators Say Marijuana Incubators Could Boost Equity While Growing Business

A set of fresh marijuana incubators and mentorship initiatives now offer support and practical training to small-scale cannabis brands and newcomers, aiming to promote equity and create opportunities for individuals affected by the consequences of the drug war. In exchange, organizers anticipate gaining advantages from local community ties and affordable labor while also inspiring employees with purpose-driven tasks. With the decline in available capital in the marijuana sector, most operators feel compelled to accomplish more with limited resources. Oscar Carrillo, who had served four years in prison for drug sales, found it discouraging that large multistate operators (MSOs) dominated the…

Continue Reading

FridayFeb 16, 2024 10:00 am

Thai Cannabis Businesses Brace for Regulatory Shakeup

Marijuana businesses in Thailand are preparing for major regulatory and legal changes as the country works to keep recreational sales in check and make the industry primarily medicinal again. The latest draft marijuana law from the Thai government is focused on eliminating the vacuum that allowed the adult-use industry to flourish after the drug was declassified as a narcotic. The new law could greatly impact the business prospects for thousands of growers and store owners, depending on how relevant authorities chose to enforce it. Some of the proposed changes include the following: Affording law enforcement more authority to enforce the…

Continue Reading

FridayFeb 16, 2024 9:00 am

Software Effective Solutions Corp. (SFWJ) Experts Work with Partners, Customers to Meet Impressive Market Growth

Research forecasts global medical marijuana space will see CAGR of 22.32% over the next decade Several key factors contribute to double-digit growth MedCana has assembled a team of pharmaceutical scientists who are some of the world’s most respected chemists Recent forecasts for the global medical marijuana sector indicate significant growth, a trend that Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) is paying close attention to. A global infrastructure and holding company in the cannabis industry, MedCana is on a mission to become the world’s premier resource for pharmaceutical cannabis products. The recent ResarchAndMarket.com article reported that the global medical marijuana…

Continue Reading

ThursdayFeb 15, 2024 4:20 pm

420 with CNW — New Study Explores How Cannabis Entourage Effect Impacts Therapeutic Benefits

A recent review that delves into the collaborative interplay of different marijuana chemical compounds, such as flavonoids, terpenes and cannabinoids, has shown that to fully understand the therapeutic potential of marijuana, it’s important to understand how the different constituents interact. Echoing sentiments expressed in the cannabis community for years, the study underscores that the effects of cannabis extend beyond only CBD and THC. The study stresses the entourage effect, which describes the complex interactions between flavonoids, terpenes, cannabinoids and other chemicals found in marijuana plants. The study, published in the scientific journal “Molecules” last month, highlights the need to explore…

Continue Reading

ThursdayFeb 15, 2024 9:45 am

New England Cannabis Convention To Be Held In Boston, MA

Businesses, leaders, enthusiasts, and service providers of the cannabis spectrum are all invited to the NECANN Boston Convention, the 2nd largest B2B cannabis industry event across the globe. Since its 70th booth convention back in 2015, NECANN has come a long way. This year’s convention will feature over 350 exhibitors, several workshops, five full programming tracks, and a day-long financial/investor summit. The age limit to attend the conference is 18+ unless accompanied by a guardian. The NECANN event is a phenomenal business platform attracting the New England cannabis trading community and other visitors. Influential cannabis industry leaders will be at…

Continue Reading

WednesdayFeb 14, 2024 4:20 pm

420 with CNW — Teenage Brains More Susceptible to Cannabis Harm

Only 35% of 12- to-17-year-olds believe that smoking cannabis at least twice a week carries a major risk, according to the 2021 National Survey on Drug Use and Health (NSDUH). This low perception of risk among teenagers is concerning and is partly fueled by the widespread availability of marijuana, leading to the mistaken belief that it is entirely safe, states Beth Ebel, a pediatrician affiliated with Seattle Children’s Hospital and the University of Washington School of Medicine. The main psychoactive ingredient in cannabis, THC, alters brain chemistry to produce a “high.” The THC may have unexpected consequences on the brain,…

Continue Reading

WednesdayFeb 14, 2024 9:45 am

Study Says Cannabis Doesn’t Up Vehicle Accident Risk But Alcohol Intake Does

A recent study has revealed that cannabis use alone is not associated with an increased risk of traffic accidents. Researchers looked at data collected from emergency departments in Portland, Oregon; Sacramento, California; and Denver, Colorado; they found that self-reported rates of acute marijuana use were linked with lower car-accident odds. Furthermore, the researchers found that alcohol has a clear connection with an increased risk of car accidents when taken by itself or alongside cannabis. The team behind the study comprised researchers from the University of California Davis, the Oregon Health and Science University, the Insurance Institute for Highway Safety, Portland…

Continue Reading

WednesdayFeb 14, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks off 2024 with FDA IND Submission for its HYPER-H23-1 Phase 1b Human Clinical Trial

Lexaria, a global innovator in drug delivery platforms, just announced the submission of its IND application with the FDA for its HYPER-H23-1 phase 1b hypertension clinical trial This study will seek to evaluate the safety and tolerability of Lexaria’s patented DehydraTECH(TM) technology, specifically DehydraTECH-CBD, in hypertensive patients Lexaria expects to build on success of its previous studies, which showed positive results and DehydraTECH-CBD’s potential to have broad therapeutic utility Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the submission of its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”)…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722